Komori
True Data (4416) · RiskDropped

Business and Accounting Impacts of COVID-19

First written in FY2022-Q3. 4 of 11 entries say "Restated". Latest entry: FY2026.

11entries
5years
0from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseRestatedFY2022 – FY2023-Q3SoftenedFY2023 – FY20252022: 420222023: 320232024: 220242025: 120252026: 12026
Same theme, other companies
Risk of COVID-19 impacts on business activities, supply chains, demand and financial performanceA theme 1257 companies write about · 1269 as a headwind · 6 as a tailwind

The whole theme swung hardest in 2020: 103 of 175 companies on the "Worse" side.

Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Showing 14 of the 196 companies compared. The sentences above are computed from all 196.Comparing 200 of the theme's 1283 threads.
Full recordFilings, disclosures and news, newest first
  1. FY2026DroppedAnnual report
    COVID-19 is no longer addressed as a specific business or accounting theme, and the risk section refers only to the spread of infectious diseases in general.
  2. FY2025ReframedAnnual report

    「During the spread of COVID-19, the Company established an environment in which employees could work entirely remotely in order to ensure their safety.」

    COVID-19 is no longer described as a business or accounting risk; instead, the remote-work environment established during the previous period of infection spread is cited in the discussion of work arrangements.
  3. FY2024SoftenedAnnual report

    「During the fiscal year, Japan’s economy saw continued normalization of socioeconomic activity following the COVID-19 pandemic, and personal consumption showed a gradual recovery as employment and income conditions improved.」

    Regarding COVID-19, the Company indicates that socioeconomic activity is continuing to normalize following the pandemic.
  4. FY2024-Q3SoftenedAnnual report

    「During the cumulative third-quarter period, Japan’s economy saw continued normalization of socioeconomic activity following the COVID-19 pandemic, while personal consumption continued to recover gradually.」

    Regarding COVID-19, the Company indicates that socioeconomic activity is continuing to normalize, representing a further easing from its previous explanation, which expressed strong concern about the impact of the infection.
  5. FY2024-Q1SoftenedAnnual report

    「As the impact of COVID-19 became limited, personal consumption showed a gradual recovery, supported by the normalization of socioeconomic activity and rising wages.」

    The Company’s economic assessment has shifted from describing a worsening social impact to judging that the impact of COVID-19 has become limited.
  6. FY2023ReframedAnnual report

    「The social impact of COVID-19 is becoming increasingly serious, and the importance of using data and technology for marketing and responding to market changes is growing not only for large companies but also for medium-sized and small companies and regional economies.」

    The discussion has shifted from the potential business and accounting impacts previously described to the social impact of the infection and the importance of using data and technology.
  7. FY2023-Q3RestatedAnnual report

    「With respect to the impact of COVID-19, it remains difficult to accurately predict how the infection will spread or when it will subside, as was the case at the end of the previous fiscal year. At present, the Company judges that COVID-19 will have a certain impact on forecasts of future cash flows and the future business environment, but that the impact will be limited. However, depending on further expansion of the impact and the timing of its containment, COVID-19 could have a material effect on accounting estimates, including judgments regarding the valuation of fixed assets and the recoverability of deferred tax assets.」

    While judging the impact of COVID-19 to be limited, the Company continues to describe the possibility that the spread of infection and the timing of its containment could affect accounting estimates.
  8. FY2023-Q2RestatedAnnual report

    「With respect to the impact of COVID-19, it remains difficult to accurately predict how the infection will spread or when it will subside, as was the case at the end of the previous fiscal year. At present, the Company judges that COVID-19 will have a certain impact on forecasts of future cash flows and the future business environment, but that the impact will be limited. However, depending on further expansion of the impact and the timing of its containment, COVID-19 could have a material effect on accounting estimates, including judgments regarding the valuation of fixed assets and the recoverability of deferred tax assets.」

    While judging the impact of COVID-19 to be limited, the Company continues to describe the possibility that the spread of infection and the timing of its containment could affect accounting estimates.
  9. FY2023-Q1RestatedAnnual report

    「With respect to the impact of COVID-19, it remains difficult to accurately predict how the infection will spread or when it will subside, as was the case at the end of the previous fiscal year. At present, the Company judges that COVID-19 will have a certain impact on forecasts of future cash flows and the future business environment, but that the impact will be limited. However, depending on further expansion of the impact and the timing of its containment, COVID-19 could have a material effect on accounting estimates, including judgments regarding the valuation of fixed assets and the recoverability of deferred tax assets.」

    While judging the impact of the infection to be limited at present despite a certain degree of impact, the Company continues to describe the possibility that the spread of infection and other factors could affect accounting estimates.
  10. FY2022RestatedAnnual report

    「If client companies’ business activities or other operations are affected by the spread of COVID-19, or if infections spread among the Company’s employees or business partners, resulting in a need to scale back business activities, the Company’s operating results and financial position could be affected. The Company has made preventing the spread of infection among employees, business partners and other stakeholders its top priority, and its decision-making bodies, including the Board of Directors, have been promptly assessing the situation and formulating measures to prevent infection. The Company has also promptly introduced measures necessary to maintain business continuity, including the transition to remote work.」

    While continuing to indicate the possibility of business impacts from the spread of infection, the Company describes business continuity measures such as the transition to remote work.
  11. FY2022-Q3MaterialisedAnnual report

    「The spread of COVID-19 has had a meaningful impact on the Company’s business, including through reductions in customers’ research spending and marketing budgets.」

    The Company states that its business has already been affected by reductions in customers’ research spending and marketing budgets. It also indicates that further spread of the infection and other factors could affect the valuation of fixed assets and the recoverability of deferred tax assets.
Moved together

"Revenue recognition and operating, ordinary and net losses" moved the same way as this thread, in the same document, in 3 of its 11 moves.

3★1
  1. ★This thread
  2. 1Revenue recognition and operating, ordinary and net losses3×

★ is this thread; numbers match the list above. The number on a line is how many documents both moved the same way in; lines between the other threads count the documents they moved together in too. Threads that move together often sit closer.

When this could move next
No upcoming earnings preview for True Data yet.
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.
Business and Accounting Impacts of COVID-19 | True Data Inc. (4416) | Komori